What is IBEX Technologies Inc. (IBXNF)?

IBEX Technologies Inc. (IBXNF) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of IBXNF?

The current price of IBXNF is $1.00. Prices are updated in real time on Stocks360.

What is IBXNF's price-to-earnings (PE) ratio?

IBXNF's trailing twelve-month PE ratio is 8.72, based on current price and earnings per share data available on Stocks360.

What is IBXNF's market capitalization?

IBXNF's market capitalization is $25,270,800.00, placing it in the small-cap tier.

IBEX Technologies Inc. (IBXNF)

Stock analysis · OTC · Healthcare · Biotechnology

$1.00

Market Cap

$25.27M

PE (TTM)

8.72

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.04

Day Range

$1.00 – $1.00

52-wk Range

$0.56 – $1.10

Avg Volume

N/A

Volume

375.00

IBEX Technologies Inc. (IBXNF) is a publicly traded company in the Healthcare sector. Latest price: $1.00. Market cap $25.27M. Trailing PE 8.72. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About IBEX Technologies Inc.

Operating internationally, with key markets spanning Canada, the United States, Germany, and the United Kingdom, IBEX Technologies Inc. focuses on the development and sale of enzymes for various biomedical purposes. Its extensive product catalog includes a range of recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, alongside Chondroitinase AC and B. The company also provides sophisticated research tools, including collagen ELISAs designed to assess the formation and breakdown of connective tissue components, as well as collagen antibodies and a liquid diamine oxidase product. Furthermore, IBEX develops and commercializes various assays specifically tailored for research into osteoarthritis. Beyond its product lines, IBEX offers specialized services like lyophilization for creating disposable medical device parts, custom fermentation, and contract manufacturing. The firm caters to a broad clientele, encompassing medical device producers, quality control laboratories, manufacturers of low molecular weight heparin, and academic research institutions. IBEX Technologies Inc. was founded in 1972 and maintains its headquarters in Montreal, Canada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	8.72×
P/S (TTM)	4.71×
P/B	2.54×
PEG	0.04×
P/FCF (TTM)	28.44×
EV / EBITDA	10.72×
EV / Sales	3.78×
Earnings Yield	11.26%
Free Cash Flow Yield	3.52%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$28.36M
Revenue (TTM)	$7.49M
Net Income (TTM)	$3.97M
Free Cash Flow (TTM)	$1.43M
Net Debt	-$6.91M
Working Capital	$8.43M
Gross Margin	69.41%
Operating Margin	-19.76%
Net Margin	51.97%
Return on Equity	33.34%
Return on Invested Capital	-9.71%